Skip to main content
. 2020 Jan 13;2020(1):CD012643. doi: 10.1002/14651858.CD012643.pub3

Cocorocchio 2011.

Notes Title: Evaluation of interim 18FDG‐PET in advanced Hodgkin lymphoma (HL) patients (PTS) treated with ChlVPP/ABVVP regimen.
(Conference abstract)
Aim

  • To evaluate the prognostic value of interim 18 FDG‐PET in advanced HL patients treated with intensified ChlVPP/ABVVP


Study design

  • Not reported


Country/treatment centre(s)

  • Italy


Number of included participants

  • 70


Inclusion criteria

  • Not reported


Exclusion criteria

  • Not reported


Treatment

  • 6 cycles of ChlVPP/ABVVP


Primary outcome measure(s)

  • Overall survival

  • Freedom from treatment failure